These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 24773673)

  • 1. Conduction disorders and transcatheter aortic valve. Clinically relevant or just a mild complication?
    Morís C; Rubín JM
    Rev Esp Cardiol (Engl Ed); 2013 Sep; 66(9):692-4. PubMed ID: 24773673
    [No Abstract]   [Full Text] [Related]  

  • 2. One-year follow-up of conduction disturbances following transcatheter aortic valve implantation.
    Salizzoni S; Anselmino M; Fornengo C; Giordana F; La Torre M; Moretti C; D'Amico M; Omedé P; Marra S; Rinaldi M; Gaita F
    J Cardiovasc Med (Hagerstown); 2015 Apr; 16(4):296-302. PubMed ID: 25719906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into new-onset rhythm conduction disorders detected by multi-detector row computed tomography after transcatheter aortic valve implantation.
    Katsanos S; van Rosendael P; Kamperidis V; van der Kley F; Joyce E; Debonnaire P; Karalis I; Bax JJ; Marsan NA; Delgado V
    Am J Cardiol; 2014 Nov; 114(10):1556-61. PubMed ID: 25245414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conduction disorders in the setting of transcatheter aortic valve implantation: a clinical perspective.
    Fraccaro C; Napodano M; Tarantini G
    Catheter Cardiovasc Interv; 2013 Jun; 81(7):1217-23. PubMed ID: 23456893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical implications of conduction abnormalities and arrhythmias after transcatheter aortic valve implantation.
    van der Boon RM; Houthuizen P; Nuis RJ; van Mieghem NM; Prinzen F; de Jaegere PP
    Curr Cardiol Rep; 2014 Jan; 16(1):429. PubMed ID: 24281975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of conduction disturbances after aortic valve intervention: current evidence.
    Martinez-Selles M; Bramlage P; Thoenes M; Schymik G
    Clin Res Cardiol; 2015 Jan; 104(1):1-12. PubMed ID: 24990451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal Implantation Depth and Adherence to Guidelines on Permanent Pacing to Improve the Results of Transcatheter Aortic Valve Replacement With the Medtronic CoreValve System: The CoreValve Prospective, International, Post-Market ADVANCE-II Study.
    Petronio AS; Sinning JM; Van Mieghem N; Zucchelli G; Nickenig G; Bekeredjian R; Bosmans J; Bedogni F; Branny M; Stangl K; Kovac J; Schiltgen M; Kraus S; de Jaegere P
    JACC Cardiovasc Interv; 2015 May; 8(6):837-846. PubMed ID: 25999108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baseline HV-interval predicts complete AV-block secondary to transcatheter aortic valve implantation.
    Shin DI; Merx MW; Meyer C; Kirmanoglou K; Hellhammer K; Ohlig J; Katsani D; Zeus T; Westenfeld R; Eickholt C; Linke A; Kelm M
    Acta Cardiol; 2015 Oct; 70(5):574-80. PubMed ID: 26567817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suicide left ventricle due to conduction disturbance following transcatheter aortic valve replacement and reversal with restoration of sinus rhythm: is there life after death?
    Ibrahim H; Barker CM; Reardon MJ; Kleiman NS
    J Invasive Cardiol; 2015 Jun; 27(6):E107-9. PubMed ID: 26028658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conduction disturbances and permanent cardiac pacing after transcatheter implantation of the CoreValve aortic bioprosthesis: initial single centre experience.
    Czerwińska K; Hryniewiecki T; Oręziak A; Dąbrowski M; Michałowska I; Witkowski A; Demkow M; Stępińska J; Orłowska Baranowska E; Rużyłło W
    Kardiol Pol; 2012; 70(2):121-8. PubMed ID: 22427074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement: the PARTNER (Placement of AoRtic TraNscathetER Valves) trial and registry.
    Nazif TM; Dizon JM; Hahn RT; Xu K; Babaliaros V; Douglas PS; El-Chami MF; Herrmann HC; Mack M; Makkar RR; Miller DC; Pichard A; Tuzcu EM; Szeto WY; Webb JG; Moses JW; Smith CR; Williams MR; Leon MB; Kodali SK;
    JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):60-9. PubMed ID: 25616819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of conduction abnormalities after transcatheter aortic valve implantation with the Medtronic-CoreValve and the effect on left ventricular ejection fraction.
    Tzikas A; van Dalen BM; Van Mieghem NM; Gutierrez-Chico JL; Nuis RJ; Kauer F; Schultz C; Serruys PW; de Jaegere PP; Geleijnse ML
    Am J Cardiol; 2011 Jan; 107(2):285-9. PubMed ID: 21129715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steroid therapy and conduction disturbances after transcatheter aortic valve implantation.
    Havakuk O; Konigstein M; Ben Assa E; Arbel Y; Abramowitz Y; Halkin A; Bazan S; Shmilovich H; Keren G; Finkelstein A; Banai S
    Cardiovasc Ther; 2016 Oct; 34(5):325-9. PubMed ID: 27273567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Timing of Onset and Outcome of New Conduction Abnormalities Following Transcatheter Aortic Valve Implantation: Role of Balloon Aortic Valvuloplasty.
    Campelo-Parada F; Nombela-Franco L; Urena M; Regueiro A; Jiménez-Quevedo P; Del Trigo M; Chamandi C; Rodríguez-Gabella T; Auffret V; Abdul-Jawad Altisent O; DeLarochellière R; Paradis JM; Dumont E; Philippon F; Pérez-Castellano N; Puri R; Macaya C; Rodés-Cabau J
    Rev Esp Cardiol (Engl Ed); 2018 Mar; 71(3):162-169. PubMed ID: 28566243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimally invasive aortic valve replacement with sutureless valve is the appropriate treatment option for high-risk patients and the "real alternative" to transcatheter aortic valve implantation.
    Glauber M; Miceli A
    J Thorac Cardiovasc Surg; 2016 Mar; 151(3):610-613. PubMed ID: 26602264
    [No Abstract]   [Full Text] [Related]  

  • 16. Transcatheter Aortic Valve Replacement and New Conduction Abnormalities/Permanent Pacemaker: Can We Achieve the Intended Implant Depth?
    Piazza N; Lauzier P; Mylotte D
    JACC Cardiovasc Interv; 2016 Feb; 9(3):255-258. PubMed ID: 26847117
    [No Abstract]   [Full Text] [Related]  

  • 17. Electrophysiological evaluation of atrioventricular conduction disturbances in transcatheter aortic valve implantation with Edwards SAPIEN prosthesis.
    Eksik A; Gul M; Uyarel H; Surgit O; Yildirim A; Uslu N; Aksu H; Turen S; Uzun F; Satılmısoglu H; Erol MK; Bakir I
    J Invasive Cardiol; 2013 Jun; 25(6):305-9. PubMed ID: 23735359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New conduction abnormalities after TAVI--frequency and causes.
    van der Boon RM; Nuis RJ; Van Mieghem NM; Jordaens L; Rodés-Cabau J; van Domburg RT; Serruys PW; Anderson RH; de Jaegere PP
    Nat Rev Cardiol; 2012 May; 9(8):454-63. PubMed ID: 22547171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in the Pacemaker Rate After Transition From Edwards SAPIEN XT to SAPIEN 3 Transcatheter Aortic Valve Implantation: The Critical Role of Valve Implantation Height.
    De Torres-Alba F; Kaleschke G; Diller GP; Vormbrock J; Orwat S; Radke R; Reinke F; Fischer D; Reinecke H; Baumgartner H
    JACC Cardiovasc Interv; 2016 Apr; 9(8):805-813. PubMed ID: 27017367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peri-aortic hematoma complicated with aortic regurgitation following transcatheter aortic valve implantation: description of a novel mechanism of paravalvular leak.
    Nombela-Franco L; Goicolea J; Oteo JF
    J Invasive Cardiol; 2012 Sep; 24(9):463-4. PubMed ID: 22954567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.